Please join the Michigan Opioid collaborative for a presentation on enhancing access to Medications for Opioid Use Disorder (MOUD). This discussion will include a group of panelists from several innovative programs in Michigan. They will share their experiences developing and working in care models that embrace low barrier principles to increase access to medications for Opioid…

Please join the Michigan Opioid Collaborative for a presentation and discussion on an Introduction to Treating Patients with Buprenorphine. This training offers 4 CME credit hours which count towards the 8 hour SUD training requirement for DEA Licensees. This course aims to help residents and new prescribers learn more about stigma/harm reduction, neurobiology of addiction,…

This knowledge-based session builds upon previous presentations reviewing the commonly encountered barriers to buprenorphine access at community pharmacies including key findings of the 2021 statewide pharmacist buprenorphine survey. The program will address common barriers including controlled substance management, knowledge deficits, and perceptions of stigma and diversion. Changes in buprenorphine availability related to removal of X-waiver…

Please join the Michigan Opioid Collaborative for a presentation and discussion on prescription PrEP. This presentation aims to help providers collect an appropriate history prior to starting HIV PrEP, common side effects, important labs to check, follow-up tests to give, and when to stop PrEP. Q&A and discussion to follow. 1 Available Credit - Meets…

Please join the Michigan Opioid Collaborative for a presentation on updated information on the clinical effects of kratom and its relationship with psychosis and aggression. The diagnosis and treatment of patients who present with symptoms of potential intoxication, psychosis, and aggression can be complicated, so other factors that may mimic or interact with kratom will…

Please join the Michigan Opioid Collaborative for a presentation on a broad overview of Alcohol Use Disorders (AUD) in the United States and highlight research-supported tools to identify and mitigate alcohol-related harms. 1 Available Credit: MCBAP credit approved CME credit approved Social Work CEU credit approved This activity has been planned and implemented in accordance…

Please join the Michigan Opioid Collaborative for a presentation by Dr. Menke. This discussion will provide an overview of the trends associated with Novel Psychoactive Substances (NPS). The emphasis will be on clinical issues associated with NPS, identifying intoxication, challenges associated with urine drug testing, and medical management. 1 Available Credit: MCBAP credit approved CME…